Prosecution Insights
Last updated: May 29, 2026

Examiner: JOSEPH, JANET

Tech Center 1600 • Art Units: 1611

This examiner grants 35% of resolved cases

Performance Statistics

34.7%
Allow Rate
-25.3% vs TC avg
67
Total Applications
+42.8%
Interview Lift
1444
Avg Prosecution Days
Based on 49 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
4.3%
§102 Novelty
59.9%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17047195 ROS-RESPONSIVE MICRONEEDLE PATCH FOR ACNE VULGARIS TREATMENT Final Rejection North Carolina State University
18084402 COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR Non-Final OA L'Oreal
17731791 COMPOSITIONS SUITABLE AS SETTERS Non-Final OA L'OREAL
17731759 COMPOSITIONS SUITABLE AS SETTERS Non-Final OA L'OREAL
17608538 Complex of Noble Metal Oxide Nanoparticles and Tellurium Nanowires and Biomedical Applications Thereof Final Rejection Northeastern University
17999061 FORMULATION CONTAINING IBUPROFEN Final Rejection RECKITT BENCKISER HEALTH LIMITED
18265464 Oral Capsule Cannabinoid Formulations Non-Final OA Pinata Holdings Inc.
18250782 MODIFIED RELEASE COMPOSITIONS COMPRISING MELATONIN Non-Final OA NUTRIVENTIA PRIVATE LIMITED
18033005 CANNABIDIOL-CONTAINING SEAMLESS SOFT CAPSULE Final Rejection Fuji Capsule Co., LTD.
18013105 PHARMACEUTICAL COMPOSITIONS FOR IMPROVED DELIVERY OF THERAPEUTIC LIPOPHILIC ACTIVES Final Rejection KARNAK TECHNOLOGIES, LLC
17268657 TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA Non-Final OA EIT Pharma, Inc.
17253077 LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTS Non-Final OA FEDSON, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month